Clinical Trials Logo

Dry Eye Syndromes clinical trials

View clinical trials related to Dry Eye Syndromes.

Filter by:

NCT ID: NCT04457999 Recruiting - Dry Eye Clinical Trials

Clinical Outcome of Lipiflow Treatment Prior to Cataract Surgery in Dry Eye Patients

Start date: March 20, 2020
Phase: N/A
Study type: Interventional

To investigate the clinical outcome of Lipiflow treatment prior to cataract surgery in patients with meibomian gland dysfunction and dry eye disease

NCT ID: NCT04297618 Recruiting - Dry Eye Clinical Trials

The Effect of Xiidra on Comfort and Dryness in Symptomatic Contact Lens Wearers

COLLIE
Start date: July 7, 2021
Phase: Phase 4
Study type: Interventional

The purpose of this study to evaluate changes in comfort and dryness in symptomatic contact lens (CL) wearers after using Xiidra (lifitegrast 5.0% ophthalmic solution) for 12 weeks.

NCT ID: NCT04235400 Recruiting - Dry Eye Disease Clinical Trials

Multimodal Screening of Dry Eye Disease

MAOS-S
Start date: January 28, 2021
Phase:
Study type: Observational

Two methods allow to evaluate tear breakup time (BUT): without prior dye instillation (No Dye BreakUp Time NDBUT) or after fluorescein instilation (FBUT). The interconnections between those two values are unknown

NCT ID: NCT04217785 Recruiting - Dry Eye Syndromes Clinical Trials

Umbilical Cord Serum Versus Conventional Eyedrops

Start date: January 20, 2020
Phase: Phase 1/Phase 2
Study type: Interventional

Dry eye disease (DED) is a chronic ocular surface disease and the prevalence of DED has been reported as high as 50%. Recently, The international Dry Eyes Workshop II (DEWS II) defines dry eye as a "multifactorial disease of the ocular surface characterized by a loss of homeostasis of the tear film, and accompanied by ocular symptoms, in which tear film instability and hyperosmolarity, ocular surface inflammation and damage, and neurosensory abnormalities play etiological roles". A study done by Yoon et al. on 31 patients with severe DED concluded that UCS eye drops are effective and safe in treating severe DED. Studies found that EGF, TGF-β, VEGF and vitamin A levels were significantly higher in UCS than peripheral blood serum(PBS) whereas IGF content was significantly higher in PBS than in CBS. Yoon et al. then conducted another study whereby he compared UCS to AS in treating both Sjögren syndrome and non- Sjögren syndrome patients with severe dry eyes. They concluded that UCS eye drops were more effective in decreasing symptoms and keratoepitheliopathy in severe dry eye syndrome and increasing goblet cell density in Sjögren syndrome compared with AS drops. Despite proven more effective in treating DED, serum eye drops are not yet widely manufactured due to a few reasons. This study is chosen because 1. Not many previous clinical trials done related to UCS eye drops. 2. There were only two clinical trials done before to compare the use of UCS eye drops versus conventional AT eye drops on Hansen's disease and acute ocular chemical burn injury population. 3. To apply the newer technology of Keratograph® 5M in DED assessment. 4. To initiate a proper standard operating procedure for production as well as delivery of serum eye drops which allowing out-patient treatment with serum eye drops possible.

NCT ID: NCT04213248 Recruiting - Dry Eye Clinical Trials

Effect of UMSCs Derived Exosomes on Dry Eye in Patients With cGVHD

Start date: February 21, 2020
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to determine whether Umbilical Mesenchymal Stem Cells (UMSCs) derived Exosomes could alleviate dry eye symptoms in patients with chronic Graft Versus Host Diseases (cGVHD).

NCT ID: NCT04198740 Recruiting - Dry Eye Syndrome Clinical Trials

Proteomic and Metabolomic Lacrimal Fingerprint in Diverse Pathologies of the Ocular Surface

EML-MSO
Start date: February 1, 2020
Phase:
Study type: Observational

This study aims to obtain the lacrimal fingerprint for frequent pathologies of the ocular surface and establish a normative base for each of them.

NCT ID: NCT04172961 Recruiting - Dry Eye Clinical Trials

Clinical Efficacy of Two Topical Dry Eye Drops for Central Corneal Stain Clearing Over 90 Days

Start date: February 1, 2020
Phase: Phase 4
Study type: Interventional

This study will be a randomized, double-blind prospective in 3 clinical sites to compare the efficacy of two currently approved topical ophthalmic drops in the clearing central corneal staining in 90 days prior to elective cataract or LASIK surgery.

NCT ID: NCT04125134 Recruiting - Dry Eye Clinical Trials

Predicting the Success of Dry Eye Disease Interventions Using Clinical Tests

PreDICT
Start date: October 3, 2019
Phase: Phase 4
Study type: Interventional

This is a single site, prospective, cross-sectional, controlled clinical study on a total of 66 subjects. The subjects are divided into two groups: Hypertonic Saline Non-Responders (33 subjects) and Hypertonic Saline Responders (33 subjects). After completion of questionnaires, the subjects will undergo Dry Eye Disease testing and functional nerve testing. Subjects who qualify will be dispensed 4 weeks of preservative free artificial tears and instructed to instill one drop into each eye twice daily. Subjects will return for a follow up visit 4 weeks later (± 4 days), during which subjects will complete the questionnaires again and the Dry Eye Disease tests and functional nerve tests will be repeated.

NCT ID: NCT04109170 Recruiting - Dry Eye Clinical Trials

Dry Eye Evaluation System Based on Bioinformatics

Start date: September 23, 2019
Phase:
Study type: Observational [Patient Registry]

Dry eye is a common ocular surface disease of multifactorial etiology characterized by elevated tear osmolality and inflammation leading to a disrupted ocular surface. The latter is a risk factor for ocular surface infection, yet overt infection is not commonly seen clinically in the typical dry eye patient. This suggests that important innate mechanisms operate to protect the dry eye from invading pathogens. Understand the pathogenesis of dry eye will be the measure to prevention and treatment of dry eye. In this essay, the investigators use the data of experiment in the patients with dry eye and normal, acquire their tear production, tear film stability, and surface damage. The investigators use weka to calculate the prediction accuracy of the 6 algorithm and select the best one, optimize the parameters to get the final prediction accuracy.

NCT ID: NCT04096898 Recruiting - Clinical trials for Moderate to Severe Dry Eye Disease

Senofilcon A Lenses in Moderate to Severe Dry Eye Disease

Start date: April 23, 2018
Phase: N/A
Study type: Interventional

A clinical trial using Senofilcon A daily lenses in the treatment of moderate to severe dry eye. This a comparison between signs and symptoms prior to and during treatment.